Clinical efficacy evaluation of crisaborole ointment in the treatment of vulvar leukoplakia-Reference-Cited by-同舟云学术

Clinical efficacy evaluation of crisaborole ointment in the treatment of vulvar leukoplakia

Published:2023-01 Issue:1 Volume:69 Page:97-100
ISSN:1806-9282
Container-title:Revista da Associação Médica Brasileira
language:
Short-container-title:Rev. Assoc. Med. Bras.

Author:

Li Lijun¹^ORCID

Affiliation:

1. Jiangxi Maternal and Child Health Hospital, China

Publisher

FapUNIFESP (SciELO)

Subject

General Medicine

Link

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0104-42302023000100097&tlng=en

Reference18 articles.

1. Associations between HLA-A\B\DRB1 polymorphisms and risks of vulvar lichen sclerosus or squamous cell hyperplasia of the vulva;Liu GL;Genet Mol Res,2015

2. Expert consensus on the treatment of female sclerosing moss;Chang JM;Chin J Dermatol,2021

3. The use of traditional Chinese medicine internally and externally combined with auricular acupuncture point bloodletting in the treatment of vulvar leukoplakia;Ji YY;TMR Integr Med,2020

4. Efficacy and safety of crisaborole ointment, a novel, nonsteroidal phosphodiesterase 4 (PDE4) inhibitor for the topical treatment of atopic dermatitis (AD) in children and adults;Paller AS;J Am Acad Dermatol,2016

5. Crisaborole topical ointment, 2% in patients ages 2 to 17 years with atopic dermatitis: a phase 1b, open-label, maximal-use systemic exposure study;Zane LT;Pediatr Dermatol,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ex-vivo skin retention of crisaborole from microemulsion and micellar formulations;Journal of Drug Delivery Science and Technology;2024-10